<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03194646</url>
  </required_header>
  <id_info>
    <org_study_id>16953</org_study_id>
    <secondary_id>2016-004822-41</secondary_id>
    <nct_id>NCT03194646</nct_id>
  </id_info>
  <brief_title>Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids</brief_title>
  <acronym>ASTEROID 6</acronym>
  <official_title>An Open-label, Parallel-group, Randomized, Multicenter Study to Assess the Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids Versus Standard of Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was performed to assess the efficacy and safety of Vilaprisan in subjects with&#xD;
      uterine fibroids compared to standard of care&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 30, 2017</start_date>
  <completion_date type="Anticipated">October 29, 2021</completion_date>
  <primary_completion_date type="Actual">May 10, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Change in Bone Mineral Density (BMD) of Lumbar Spine</measure>
    <time_frame>From baseline to about 1 year after start of treatment</time_frame>
    <description>The percentage change in BMD (measured by dual-energy X-ray absorptiometry (DEXA) scan) of lumbar spine from baseline to about one year after start of treatment (SoT) in all randomized and treated participants with measurements at those 2 time points in each treatment group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Bleeding Days</measure>
    <time_frame>Approximately 1 year</time_frame>
    <description>Number of bleeding days were defined from Day 1 of the first treatment period until the day before a new treatment period would start again following the last treatment period for that respective treatment group. Number to be normalized by 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endometrial Histology</measure>
    <time_frame>Approximately 1 year</time_frame>
    <description>Number of participants with endometrial histology findings, e.g. benign endometrium, presence or absence of hyperplasia or malignancy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endometrial Thickness</measure>
    <time_frame>Treatment phase: appximately 1 year, follow-up phase: up to 2 years</time_frame>
    <description>Ultrasound examinations were performed. Endometrial thickness was measured in the medio-sagittal section as double-layer in millimeters. Summary statistics for change from baseline in endometrial thickness was provided in below table.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage Change From Baseline in BMD Measured at Lumbar Spine (Other Time Points Not Mentioned as Primary Safety Variable) and Hip/Femoral Neck</measure>
    <time_frame>Up to 2 years</time_frame>
    <description>Percentage change in BMD (measured by dual-energy X-ray absorptiometry (DEXA) scan) of lumbar spine (other time points not mentioned as primary safety analysis), hip, and femoral neck from baseline was analyzed using the same statistical methods as used for the primary variable.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1272</enrollment>
  <condition>Leiomyoma</condition>
  <arm_group>
    <arm_group_label>A1(3/1 regimen)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.0 mg treatment of 12 weeks, each separated by 1 bleeding break</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2(6/2 regimen)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.0 mg treatment period of 24 weeks, each separated by 2 bleeding break</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A3(3/2 regimen)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.0 mg treatment period of 12 weeks, each separated by 2 bleeding break</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B(Standard of care)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care as determined by the investigators, this could be watch &amp; wait or non-hormonal medical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vilaprisan (BAY1002670)</intervention_name>
    <description>2 mg of Vilaprisan once daily for 12 weeks, 4 treatment periods of 12 weeks, each separated by 1 bleeding episode (3/1 regimen).</description>
    <arm_group_label>A1(3/1 regimen)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vilaprisan (BAY1002670)</intervention_name>
    <description>2 mg of Vilaprisan once daily for 24 weeks, 2 treatment periods of 24 weeks, each separated by 2 bleeding episodes (6/2 regimen).</description>
    <arm_group_label>A2(6/2 regimen)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vilaprisan (BAY1002670)</intervention_name>
    <description>2 mg of Vilaprisan once daily for 12 weeks, 4 treatment periods of 12 weeks, each separated by 2 bleeding episodes (3/2 regimen).</description>
    <arm_group_label>A3(3/2 regimen)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Standard of care as determined by the investigators (including watch and wait, symptomatic nonhormonal)</description>
    <arm_group_label>B(Standard of care)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vilaprisan (BAY1002670)</intervention_name>
    <description>2 mg of Vilaprisan once daily for 12 weeks, 8 treatment periods of 12 weeks, each separated by 1 bleeding episode (3/1 regimen)</description>
    <arm_group_label>A1(3/1 regimen)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vilaprisan (BAY1002670)</intervention_name>
    <description>2 mg of Vilaprisan once daily for 24 weeks, 4 treatment periods of 24 weeks, each separated by 2 bleeding episodes (6/2 regimen)</description>
    <arm_group_label>A2(6/2 regimen)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vilaprisan (BAY1002670)</intervention_name>
    <description>2 mg of Vilaprisan once daily for 12 weeks, 6 treatment periods of 12 weeks, each separated by 2 bleeding episodes (3/2 regimen)</description>
    <arm_group_label>A3(3/2 regimen)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Diagnosis of uterine fibroid(s) documented by ultrasound at screening AND/OR during a&#xD;
             uterine preserving procedure within 3 months prior to screening in subjects with high&#xD;
             risk for recurrence&#xD;
&#xD;
          -  At least one symptom of uterine fibroid(s) - bleeding, pelvic pressure/pain&#xD;
&#xD;
          -  Good general health&#xD;
&#xD;
          -  Normal or clinically insignificant cervical smear&#xD;
&#xD;
          -  An endometrial biopsy performed during the screening period, without significant&#xD;
             histological disorder&#xD;
&#xD;
          -  Use of an acceptable nonhormonal method of contraception starting at Visit 1 until the&#xD;
             end of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or lactation (less than 3 months since delivery, abortion, or lactation&#xD;
             before start of treatment)&#xD;
&#xD;
          -  Hypersensitivity to any ingredient of the study drug&#xD;
&#xD;
          -  Any condition requiring immediate blood transfusion&#xD;
&#xD;
          -  Any diseases, conditions, or medications that can compromise the function of the body&#xD;
             systems and could result in altered absorption, excessive accumulation, impaired&#xD;
             metabolism, or altered excretion of the study drug&#xD;
&#xD;
          -  Any diseases or conditions that might interfere with the conduct of the study or the&#xD;
             interpretation of the results&#xD;
&#xD;
          -  Abuse of alcohol, drugs, or medicines (eg, laxatives)&#xD;
&#xD;
          -  Use of other treatments that might interfere with the conduct of the study or the&#xD;
             interpretation of the results&#xD;
&#xD;
          -  Undiagnosed abnormal genital bleeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Research Associates, Inc.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Health Alliance of Mobile</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Clinical Research, Inc</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Visions Clinical Research - Tucson</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lynn Institute of the Ozarks</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnamics, Inc.</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grossmont Center for Clinical Research</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center for Clinical Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Womens Health Care Research Corporation</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Coast OB/GYN Associates</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Women's Health Institute</name>
      <address>
        <city>Greenwood Village</city>
        <state>Colorado</state>
        <zip>80111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physicians Research Options, LLC</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stamford Hospital</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Dr. James A. Simon, MD</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helix Biomedics, LLC</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Medical Research Group, LLC</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33759</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Victoria Garcia &amp; Associates, LLC Doral Medical Research</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M &amp; O Clinical Research, LLC</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Solutions Through Advanced Research, Inc.</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Axcess Medical Research, LLC</name>
      <address>
        <city>Loxahatchee Groves</city>
        <state>Florida</state>
        <zip>33470</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Suncoast Clinical Research Center, Inc.</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34652</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Suncoast Clinical Research</name>
      <address>
        <city>Palm Harbor</city>
        <state>Florida</state>
        <zip>34684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ONCOVA Clinical Research, Inc.</name>
      <address>
        <city>Saint Cloud</city>
        <state>Florida</state>
        <zip>34769</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physician Care Clinical Research</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Agile Clinical Research Trials, LLC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Women's Research Institute, Inc.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisense Inc at Atlantic Station</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30364</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University Medical Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paramount Research Solutions-College Park</name>
      <address>
        <city>College Park</city>
        <state>Georgia</state>
        <zip>30349</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fellows Research Alliance</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Journey Medical Research</name>
      <address>
        <city>Snellville</city>
        <state>Georgia</state>
        <zip>30078</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center For Women's Research</name>
      <address>
        <city>Palos Heights</city>
        <state>Illinois</state>
        <zip>60463</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Professional Research Network of Kansas, LLC</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67205-1138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Integrity, LLC</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praetorian Pharmaceutical Research, LLC</name>
      <address>
        <city>Marrero</city>
        <state>Louisiana</state>
        <zip>70072</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Clinical Research Associates LLC</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omni Fertility and Laser Institute</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baltimore Suburban Health, LLC</name>
      <address>
        <city>Pikesville</city>
        <state>Maryland</state>
        <zip>21208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Continental Clinical Solutions, LLC</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University Physicians Group</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Clinic of Lincoln, PC</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Research - Clinical Research Center of Nevada, LLC</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lawrence OB/GYN Associates</name>
      <address>
        <city>Lawrenceville</city>
        <state>New Jersey</state>
        <zip>08648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jersey Shore University Medical Center</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bosque Womens Care</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manhattan Medical Research</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richmond ObGyn Associates PC</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Healthcare System</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Women's Research &amp; Wellness Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unified Women's Clinical Research</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27408</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unified Women's Clinical Research - Morehead City</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Carolina Women's Center</name>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <zip>28562</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Health Alliance</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Wilmington</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyndhurst Clinical Research</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valaoras &amp; Lewis OB/GYN</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Inquest Center, Ltd.</name>
      <address>
        <city>Beavercreek</city>
        <state>Ohio</state>
        <zip>45432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409-2793</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HWC Women's Research Center</name>
      <address>
        <city>Englewood</city>
        <state>Ohio</state>
        <zip>45322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033-0850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drexel University College of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research of Philadelphia, LLC</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vista Clinical Research</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VitaLink Research - Greenville</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Venus Gynecology, LLC former Magnolia OB/GYN Research Center</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29572</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Invocare Clinical Research Center, LLC</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <zip>29169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ClinSearch, LLC</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Physician Group</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Discovery Clinical Trials</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Signature GYN Services, Pllc</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104-4145</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Dr. Delbert Alan Johns, MD</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Willowbend Health &amp; Wellness Associates</name>
      <address>
        <city>Frisco</city>
        <state>Texas</state>
        <zip>75035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advances in Health, Inc.</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Woman's Hospital of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centex Studies, Inc.</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MacArthur OB/GYN Mangement, LLC</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Medicine Clinic</name>
      <address>
        <city>Lampasas</city>
        <state>Texas</state>
        <zip>76550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seven Oaks Women's Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OB-GYN Physicians, Inc.</name>
      <address>
        <city>Franklin</city>
        <state>Virginia</state>
        <zip>23851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tidewater Physicians for Women</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Physicians For Women</name>
      <address>
        <city>North Chesterfield</city>
        <state>Virginia</state>
        <zip>23235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of Viriginia</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Synexus Research, LLC</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MultiCare Health Systems Women's Health Care</name>
      <address>
        <city>Covington</city>
        <state>Washington</state>
        <zip>98042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>900th Hospital of Joint Logistics Support Force</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hosp. Sun Yat-Sen Univ.</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou University of TCM</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510405</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518036</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Guangxi Zhuang Autonomous Region</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hainan General Hospital</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570311</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The 2nd Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Reproductive Medicine,Tongji Medical college,HUST</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing Maternity and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jiangxi Maternal and Child Health Hospital</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Second University Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <zip>830054</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Hospital School of Medicine Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affliated Hospital of Wenzhou Medicial University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <zip>100010</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Obstetrics and Gynecology Hospital,Capital Med.Uni.</name>
      <address>
        <city>Beijing</city>
        <zip>100026</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital, Captial Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital CAMS</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Peace Maternity&amp;Child Health Hospital of CWI</name>
      <address>
        <city>Shanghai</city>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Changhai Hospital of Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Teaching Hosptial of Tianjin University of TCM</name>
      <address>
        <city>Tianjin</city>
        <zip>300193</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin Central Hospital of Gynecology obstetrics</name>
      <address>
        <city>Tianjin</city>
        <zip>300199</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Nemocnice Brno</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Nemocnice Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MUDr. Radek Fiker s.r.o.</name>
      <address>
        <city>Jihlava</city>
        <zip>586 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G-Centrum Olomouc s.r.o. Dr. Skrivanek</name>
      <address>
        <city>Olomouc</city>
        <zip>772 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Nemocnice Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum gynekologicke rehabilitace</name>
      <address>
        <city>Pisek</city>
        <zip>39701</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Smrhova-Kovacs</name>
      <address>
        <city>Tabor</city>
        <zip>39003</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologie MUDr. Pavlina Nejedla s.r.o.</name>
      <address>
        <city>Vodnany</city>
        <zip>389 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mehil채inen Kuopio</name>
      <address>
        <city>Kuopio</city>
        <zip>70100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L채채k채rikeskus Gyneko</name>
      <address>
        <city>Oulu</city>
        <zip>90100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hongkong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kano's Clinic for Women</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>460-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoritsu Narashinodai Hospital</name>
      <address>
        <city>Funabashi</city>
        <state>Chiba</state>
        <zip>274-0063</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Juno Vesta Clinic Hatta</name>
      <address>
        <city>Matsudo</city>
        <state>Chiba</state>
        <zip>270-2267</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iizuka Hospital</name>
      <address>
        <city>Iizuka</city>
        <state>Fukuoka</state>
        <zip>820-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jusendo Geneal Hospital Yuasa Foundation</name>
      <address>
        <city>Koriyama</city>
        <state>Fukushima</state>
        <zip>963-8585</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sato Hospital</name>
      <address>
        <city>Takasaki</city>
        <state>Gunma</state>
        <zip>370-0836</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primo Women's Clinic</name>
      <address>
        <city>Ebetsu</city>
        <state>Hokkaido</state>
        <zip>067-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Maternity Women's Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>001-0013</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Shiroishi Obstetrics and Gynecology Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>003-0005</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hashimoto Clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>004-0052</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ena Odori Clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Maternity Women's Minami1jo Clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SAPPORO MEDICAL CENTER, NTT East Corporation</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo West Ladies Clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>063-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yoshio Clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>064-0808</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ishikawa Prefectural Central Hospital</name>
      <address>
        <city>Kanazawa</city>
        <state>Ishikawa</state>
        <zip>920-8530</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asahi clinic</name>
      <address>
        <city>Takamatsu</city>
        <state>Kagawa</state>
        <zip>760-0076</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kagawa Prefectural Central Hospital</name>
      <address>
        <city>Takamatsu</city>
        <state>Kagawa</state>
        <zip>760-8557</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Second Kawasaki Saiwai Clinic</name>
      <address>
        <city>Kawasaki</city>
        <state>Kanagawa</state>
        <zip>212-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kurashiki Medical Clinic</name>
      <address>
        <city>Kurashiki</city>
        <state>Okayama</state>
        <zip>710-0824</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Suita Municipal Hospital</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>564-0082</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Topia Soka Hospital</name>
      <address>
        <city>Soka</city>
        <state>Saitama</state>
        <zip>340-0028</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fuyo Association Seirei Numazu Hospital</name>
      <address>
        <city>Numazu</city>
        <state>Shizuoka</state>
        <zip>410-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sei Womens Clinic</name>
      <address>
        <city>Bunkyo</city>
        <state>Tokyo</state>
        <zip>112-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ginza Yoshida Clinic</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's wellness Tsushima Ruriko josei life clinic Ginza</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.Luke's International Hospital</name>
      <address>
        <city>Chuoku</city>
        <state>Tokyo</state>
        <zip>104-8560</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akazawa Clinic</name>
      <address>
        <city>Fuchu</city>
        <state>Tokyo</state>
        <zip>183-0056</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Corp. Seikoukai New Medical Research System Clinic</name>
      <address>
        <city>Hachioji</city>
        <state>Tokyo</state>
        <zip>192-0046</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yokokura Clinic</name>
      <address>
        <city>Minato-ku</city>
        <state>Tokyo</state>
        <zip>108-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toranomon Womens Clinic</name>
      <address>
        <city>Minato</city>
        <state>Tokyo</state>
        <zip>105-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akasakamitsuke Miyazaki Obstetrics and Gynecology Clinic</name>
      <address>
        <city>Minato</city>
        <state>Tokyo</state>
        <zip>107-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shirokane Ladies' Clinic</name>
      <address>
        <city>Minato</city>
        <state>Tokyo</state>
        <zip>108-0071</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kugayama Hospital</name>
      <address>
        <city>Setagaya-ku</city>
        <state>Tokyo</state>
        <zip>157-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Women's Medical University Hospital</name>
      <address>
        <city>Shinjuku-ku</city>
        <state>Tokyo</state>
        <zip>162-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ikebukuro Metropolitan Clinic</name>
      <address>
        <city>Toshima-ku</city>
        <state>Tokyo</state>
        <zip>171-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kato Internal medicine and Gynecology Clinic</name>
      <address>
        <city>Fukui</city>
        <zip>910-0845</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sano Wemen's Clinic</name>
      <address>
        <city>Fukuoka</city>
        <zip>810-0062</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unoki Clinic</name>
      <address>
        <city>Kagoshima</city>
        <zip>892-0826</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical corporation keizukai Chayamachi Ladies Clinic</name>
      <address>
        <city>Osaka</city>
        <zip>530-0013</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chayamachi ladies Clinic Hommachi</name>
      <address>
        <city>Osaka</city>
        <zip>541-0048</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Corporation Koshinkai Nomura Clinic Namba</name>
      <address>
        <city>Osaka</city>
        <zip>542-0076</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Izuma Clinic</name>
      <address>
        <city>Osaka</city>
        <zip>543-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shizuoka Saiseikai General Hospital</name>
      <address>
        <city>Shizuoka</city>
        <zip>422-8527</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shizuoka City Shimizu Hospital</name>
      <address>
        <city>Shizuoka</city>
        <zip>424-8636</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario &quot;Jos챕 Eleuterio Gonz찼lez&quot;</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Integral M챕dico de San Juan del R챠o S. C.</name>
      <address>
        <city>San Juan del R챠o</city>
        <state>Quer챕taro</state>
        <zip>76800</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio Alcocer Pozo S. A. de C. V.</name>
      <address>
        <city>Quer챕taro</city>
        <zip>76000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kirkeparken Spesialistpraksis</name>
      <address>
        <city>Fredrikstad</city>
        <zip>1605</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nesttun Spesialistpraksis AS</name>
      <address>
        <city>Nesttun</city>
        <zip>5221</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medicus AS</name>
      <address>
        <city>Trondheim</city>
        <zip>7014</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prywatna Klinika Ginekologiczno-Poloznicza</name>
      <address>
        <city>Bialystok</city>
        <zip>15-244</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CLINICAL MEDICAL RESEARCH Sp. z o. o.</name>
      <address>
        <city>Katowice</city>
        <zip>40-156</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vita Longa Sp. z o.o.</name>
      <address>
        <city>Katowice</city>
        <zip>40-748</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gyncentrum Sp. z o.o.</name>
      <address>
        <city>Katowice</city>
        <zip>40-851</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prywatny Gabinet Lekarski Ginekologia, Poloznictwo i Ultr.</name>
      <address>
        <city>Lodz</city>
        <zip>90-602</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Chodzki</name>
      <address>
        <city>Lublin</city>
        <zip>20-093</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specjalistyczny Gabinet Ginekologiczno-Polozniczy</name>
      <address>
        <city>Lublin</city>
        <zip>20-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scientific Center of family health &amp; human reprod. problems</name>
      <address>
        <city>Irkutsk</city>
        <zip>664003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital #2</name>
      <address>
        <city>Krasnodar</city>
        <zip>350012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krasnoyarsk regional perinatal center</name>
      <address>
        <city>Krasnoyarsk</city>
        <zip>660074</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #13</name>
      <address>
        <city>Moscow</city>
        <zip>115280</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrinology Scientific Centre</name>
      <address>
        <city>Moscow</city>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Close Joint Stock Company &quot;Medical Company IDK&quot;</name>
      <address>
        <city>Samara</city>
        <zip>443067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg Medical University n.a. I.P. Pavlov</name>
      <address>
        <city>St. Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Granti-Med&quot;</name>
      <address>
        <city>St. Petersburg</city>
        <zip>198329</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scien. Res. Institute of Obsterics, Gyn. &amp; Reproduction</name>
      <address>
        <city>St. Petersburg</city>
        <zip>199034</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr L Reynders Practice</name>
      <address>
        <city>Lyttelton Manor</city>
        <state>Gauteng</state>
        <zip>0141</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pretoria, Clinical Research Unit</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0002</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Femway Inc</name>
      <address>
        <city>Umhlanga</city>
        <state>Kwazulu-Natal</state>
        <zip>4321</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durban International Clinical Research Site</name>
      <address>
        <city>Wentworth</city>
        <state>Kwazulu-Natal</state>
        <zip>4052</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drs AEVITAS Clinic (Pty) Ltd</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7405</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cape Town Clinical Research Centre</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7925</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clintrials Centre for Clinical Research</name>
      <address>
        <city>Panorama</city>
        <state>Western Cape</state>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chulalongkorn Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital, Mahidol</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cukurova Universitesi Tip Fakultesi Hastanesi</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ankara Universitesi Tip Fakultesi Hastanesi</name>
      <address>
        <city>Ankara</city>
        <zip>6100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etlik Zubeyde Hanim Kadin Hastaliklari Egitim Arastirma Hast</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uludag Universitesi Tip Fakultesi</name>
      <address>
        <city>Bursa</city>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istanbul Universitesi Istanbul Tip Fakultesi</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istanbul Universitesi Cerrahpasa-Cerrahpasa Tip Fakultesi</name>
      <address>
        <city>Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
    <country>Czechia</country>
    <country>Finland</country>
    <country>Hong Kong</country>
    <country>Japan</country>
    <country>Mexico</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>South Africa</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Colombia</country>
    <country>Spain</country>
  </removed_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 20, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2017</study_first_posted>
  <results_first_submitted>June 21, 2021</results_first_submitted>
  <results_first_submitted_qc>August 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 26, 2021</results_first_posted>
  <disposition_first_submitted>March 17, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>August 4, 2021</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">August 26, 2021</disposition_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Uterine Fibroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Availability of this study's data will later be determined according to Bayer's commitment to the EFPIA/PhRMA &quot;Principles for responsible clinical trial data sharing&quot;. This pertains to scope, timepoint and process of data access. As such, Bayer commits to sharing upon request from qualified researchers patient-level clinical trial data, study-level clinical trial data, and protocols from clinical trials in patients for medicines and indications approved in the US and EU as necessary for conducting legitimate research. This applies to data on new medicines and indications that have been approved by the EU and US regulatory agencies on or after January 01, 2014. Interested researchers can use www.clinicalstudydatarequest.com to request access to anonymized patient-level data and supporting documents from clinical studies to conduct research. Information on the Bayer criteria for listing studies and other relevant information is provided in the Study sponsors section of the portal.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 17, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT03194646/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 4, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT03194646/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted at 219 study centers in 13 countries worldwide between 30-Jun-2017 (first participant first visit) and 10-May-2019 (Primary completion date).</recruitment_details>
      <pre_assignment_details>Overall, 2368 participants were screened. Of the 2368 screened participants, 1096 (46.3%) participants were not randomized to treatment due to screen failures. 1272 (53.7%) participants were randomized and 1238 (52.3%) participants received study treatment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
          <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode</description>
        </group>
        <group group_id="P2">
          <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
          <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
        </group>
        <group group_id="P3">
          <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
          <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
        </group>
        <group group_id="P4">
          <title>B (Standard of Care)</title>
          <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="363"/>
                <participants group_id="P2" count="361"/>
                <participants group_id="P3" count="183"/>
                <participants group_id="P4" count="365"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="349"/>
                <participants group_id="P2" count="347"/>
                <participants group_id="P3" count="177"/>
                <participants group_id="P4" count="365"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="93"/>
                <participants group_id="P3" count="44"/>
                <participants group_id="P4" count="85"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="302"/>
                <participants group_id="P2" count="268"/>
                <participants group_id="P3" count="139"/>
                <participants group_id="P4" count="280"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="35"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliance with study drug</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="87"/>
                <participants group_id="P2" count="67"/>
                <participants group_id="P3" count="34"/>
                <participants group_id="P4" count="31"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site terminated by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study terminated by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="61"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="34"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="131"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants in Full analysis set (FAS) was analyzed. The FAS consisted of all randomized subjects, excluding randomized subjects who did not start treatment Period 1 (never received study drug) due to the study being temporarily paused, including 1264 participants.</population>
      <group_list>
        <group group_id="B1">
          <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
          <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode</description>
        </group>
        <group group_id="B2">
          <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
          <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
        </group>
        <group group_id="B3">
          <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
          <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
        </group>
        <group group_id="B4">
          <title>B (Standard of Care)</title>
          <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="361"/>
            <count group_id="B2" value="357"/>
            <count group_id="B3" value="181"/>
            <count group_id="B4" value="365"/>
            <count group_id="B5" value="1264"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="361"/>
                    <count group_id="B2" value="357"/>
                    <count group_id="B3" value="181"/>
                    <count group_id="B4" value="365"/>
                    <count group_id="B5" value="1264"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.7" spread="5.9"/>
                    <measurement group_id="B2" value="41.6" spread="6.0"/>
                    <measurement group_id="B3" value="41.9" spread="6.0"/>
                    <measurement group_id="B4" value="42.2" spread="6.1"/>
                    <measurement group_id="B5" value="41.9" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="361"/>
                    <count group_id="B2" value="357"/>
                    <count group_id="B3" value="181"/>
                    <count group_id="B4" value="365"/>
                    <count group_id="B5" value="1264"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="361"/>
                    <measurement group_id="B2" value="357"/>
                    <measurement group_id="B3" value="181"/>
                    <measurement group_id="B4" value="365"/>
                    <measurement group_id="B5" value="1264"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="361"/>
                    <count group_id="B2" value="357"/>
                    <count group_id="B3" value="181"/>
                    <count group_id="B4" value="365"/>
                    <count group_id="B5" value="1264"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="35"/>
                    <measurement group_id="B5" value="114"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="330"/>
                    <measurement group_id="B2" value="319"/>
                    <measurement group_id="B3" value="166"/>
                    <measurement group_id="B4" value="327"/>
                    <measurement group_id="B5" value="1142"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="361"/>
                    <count group_id="B2" value="357"/>
                    <count group_id="B3" value="181"/>
                    <count group_id="B4" value="365"/>
                    <count group_id="B5" value="1264"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="64"/>
                    <measurement group_id="B4" value="129"/>
                    <measurement group_id="B5" value="443"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="100"/>
                    <measurement group_id="B5" value="331"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="71"/>
                    <measurement group_id="B4" value="132"/>
                    <measurement group_id="B5" value="462"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline bone mineral density (BMD) of lumbar spine, hip and femoral neck</title>
          <description>The baseline data of BMD measured by dual-energy X-ray absorptiometry (DEXA) scan for lumbar spine, hip and femoral neck is provided in below table.</description>
          <population>Safety analysis set (SAF) was analyzed. SAF: All participants randomized to vilaprisan treatment groups who took at least 1 dose of study drug and all participants randomized to group B (standard of care) treatment group were included in the SAF. Participants were analyzed as treated. Some data in baseline was missing.</population>
          <units>g/cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Lumbar spine</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="338"/>
                    <count group_id="B3" value="174"/>
                    <count group_id="B4" value="350"/>
                    <count group_id="B5" value="1201"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.1468" spread="0.1869"/>
                    <measurement group_id="B2" value="1.1653" spread="0.1889"/>
                    <measurement group_id="B3" value="1.1560" spread="0.1807"/>
                    <measurement group_id="B4" value="1.1531" spread="0.1850"/>
                    <measurement group_id="B5" value="1.1552" spread="0.1859"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="341"/>
                    <count group_id="B2" value="337"/>
                    <count group_id="B3" value="174"/>
                    <count group_id="B4" value="357"/>
                    <count group_id="B5" value="1209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.0000" spread="0.1527"/>
                    <measurement group_id="B2" value="1.0046" spread="0.1614"/>
                    <measurement group_id="B3" value="1.0063" spread="0.1508"/>
                    <measurement group_id="B4" value="0.9945" spread="0.1487"/>
                    <measurement group_id="B5" value="1.0006" spread="0.1536"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="341"/>
                    <count group_id="B2" value="337"/>
                    <count group_id="B3" value="174"/>
                    <count group_id="B4" value="357"/>
                    <count group_id="B5" value="1209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.9052" spread="0.1699"/>
                    <measurement group_id="B2" value="0.9174" spread="0.1807"/>
                    <measurement group_id="B3" value="0.9150" spread="0.1730"/>
                    <measurement group_id="B4" value="0.9021" spread="0.1703"/>
                    <measurement group_id="B5" value="0.9091" spread="0.1734"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Endometrial thickness</title>
          <description>Ultrasound examinations were performed. Endometrial thickness was measured in the medio-sagittal section as double-layer in millimeters. Baseline data of endometrial thickness is provided in below table.</description>
          <population>Safety analysis set (SAF) was analyzed. SAF: All participants randomized to vilaprisan treatment groups who took at least 1 dose of study drug and all participants randomized to group B (standard of care) treatment group were included in the SAF. Participants were analyzed as treated. Some data in baseline were missing.</population>
          <units>Millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="348"/>
                    <count group_id="B2" value="344"/>
                    <count group_id="B3" value="176"/>
                    <count group_id="B4" value="363"/>
                    <count group_id="B5" value="1231"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.3" spread="3.8"/>
                    <measurement group_id="B2" value="8.3" spread="4.0"/>
                    <measurement group_id="B3" value="8.6" spread="3.8"/>
                    <measurement group_id="B4" value="8.7" spread="4.3"/>
                    <measurement group_id="B5" value="8.5" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Change in Bone Mineral Density (BMD) of Lumbar Spine</title>
        <description>The percentage change in BMD (measured by dual-energy X-ray absorptiometry (DEXA) scan) of lumbar spine from baseline to about one year after start of treatment (SoT) in all randomized and treated participants with measurements at those 2 time points in each treatment group.</description>
        <time_frame>From baseline to about 1 year after start of treatment</time_frame>
        <population>Safety analysis set (SAF) was analyzed. SAF: All participants randomized to vilaprisan treatment groups who took at least 1 dose of study drug and all participants randomized to group B (standard of care) treatment group were included in the SAF. Participants were analyzed as treated. Overall number of participants analyzed represents number of participants without missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
            <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode</description>
          </group>
          <group group_id="O2">
            <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
            <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O3">
            <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
            <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O4">
            <title>B (Standard of Care)</title>
            <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Change in Bone Mineral Density (BMD) of Lumbar Spine</title>
          <description>The percentage change in BMD (measured by dual-energy X-ray absorptiometry (DEXA) scan) of lumbar spine from baseline to about one year after start of treatment (SoT) in all randomized and treated participants with measurements at those 2 time points in each treatment group.</description>
          <population>Safety analysis set (SAF) was analyzed. SAF: All participants randomized to vilaprisan treatment groups who took at least 1 dose of study drug and all participants randomized to group B (standard of care) treatment group were included in the SAF. Participants were analyzed as treated. Overall number of participants analyzed represents number of participants without missing data.</population>
          <units>Percentage change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="113"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="57"/>
                <count group_id="O4" value="180"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.55" spread="2.70"/>
                    <measurement group_id="O2" value="-2.04" spread="2.50"/>
                    <measurement group_id="O3" value="-1.51" spread="2.28"/>
                    <measurement group_id="O4" value="0.30" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.44</ci_lower_limit>
            <ci_upper_limit>-1.26</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.34</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.87</ci_lower_limit>
            <ci_upper_limit>-1.81</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.50</ci_lower_limit>
            <ci_upper_limit>-1.11</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Bleeding Days</title>
        <description>Number of bleeding days were defined from Day 1 of the first treatment period until the day before a new treatment period would start again following the last treatment period for that respective treatment group. Number to be normalized by 28 days</description>
        <time_frame>Approximately 1 year</time_frame>
        <population>FAS was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
            <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode</description>
          </group>
          <group group_id="O2">
            <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
            <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O3">
            <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
            <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O4">
            <title>B (Standard of Care)</title>
            <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Bleeding Days</title>
          <description>Number of bleeding days were defined from Day 1 of the first treatment period until the day before a new treatment period would start again following the last treatment period for that respective treatment group. Number to be normalized by 28 days</description>
          <population>FAS was analyzed.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="349"/>
                <count group_id="O2" value="347"/>
                <count group_id="O3" value="177"/>
                <count group_id="O4" value="365"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.57" spread="1.99"/>
                    <measurement group_id="O2" value="1.74" spread="2.52"/>
                    <measurement group_id="O3" value="1.81" spread="1.24"/>
                    <measurement group_id="O4" value="4.72" spread="4.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Endometrial Histology</title>
        <description>Number of participants with endometrial histology findings, e.g. benign endometrium, presence or absence of hyperplasia or malignancy</description>
        <time_frame>Approximately 1 year</time_frame>
        <population>SAF was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
            <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode (3/1 regimen)</description>
          </group>
          <group group_id="O2">
            <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
            <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O3">
            <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
            <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O4">
            <title>B (Standard of Care)</title>
            <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
          </group>
        </group_list>
        <measure>
          <title>Endometrial Histology</title>
          <description>Number of participants with endometrial histology findings, e.g. benign endometrium, presence or absence of hyperplasia or malignancy</description>
          <population>SAF was analyzed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="349"/>
                <count group_id="O2" value="347"/>
                <count group_id="O3" value="177"/>
                <count group_id="O4" value="365"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adequate endometrial tissue</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="349"/>
                    <count group_id="O2" value="347"/>
                    <count group_id="O3" value="177"/>
                    <count group_id="O4" value="365"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="348"/>
                    <measurement group_id="O2" value="347"/>
                    <measurement group_id="O3" value="177"/>
                    <measurement group_id="O4" value="364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Benign Endometrium</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="348"/>
                    <count group_id="O2" value="347"/>
                    <count group_id="O3" value="177"/>
                    <count group_id="O4" value="364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="346"/>
                    <measurement group_id="O2" value="347"/>
                    <measurement group_id="O3" value="175"/>
                    <measurement group_id="O4" value="364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperplasia 2014, no atypia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="348"/>
                    <count group_id="O2" value="347"/>
                    <count group_id="O3" value="177"/>
                    <count group_id="O4" value="364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperplasia 2014, atypia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="348"/>
                    <count group_id="O2" value="347"/>
                    <count group_id="O3" value="177"/>
                    <count group_id="O4" value="364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malignant Neoplasm</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="348"/>
                    <count group_id="O2" value="347"/>
                    <count group_id="O3" value="177"/>
                    <count group_id="O4" value="364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endometrial Polyps</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="348"/>
                    <count group_id="O2" value="347"/>
                    <count group_id="O3" value="177"/>
                    <count group_id="O4" value="364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Endometrial Thickness</title>
        <description>Ultrasound examinations were performed. Endometrial thickness was measured in the medio-sagittal section as double-layer in millimeters. Summary statistics for change from baseline in endometrial thickness was provided in below table.</description>
        <time_frame>Treatment phase: appximately 1 year, follow-up phase: up to 2 years</time_frame>
        <population>SAF was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
            <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode (3/1 regimen)</description>
          </group>
          <group group_id="O2">
            <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
            <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O3">
            <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
            <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O4">
            <title>B (Standard of Care)</title>
            <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
          </group>
        </group_list>
        <measure>
          <title>Endometrial Thickness</title>
          <description>Ultrasound examinations were performed. Endometrial thickness was measured in the medio-sagittal section as double-layer in millimeters. Summary statistics for change from baseline in endometrial thickness was provided in below table.</description>
          <population>SAF was analyzed.</population>
          <units>Millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="349"/>
                <count group_id="O2" value="347"/>
                <count group_id="O3" value="177"/>
                <count group_id="O4" value="365"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Treatment phase</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="265"/>
                    <count group_id="O2" value="319"/>
                    <count group_id="O3" value="128"/>
                    <count group_id="O4" value="317"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="5.7"/>
                    <measurement group_id="O2" value="10.5" spread="6.3"/>
                    <measurement group_id="O3" value="9.8" spread="4.9"/>
                    <measurement group_id="O4" value="10.5" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Follow up phase</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="322"/>
                    <count group_id="O2" value="304"/>
                    <count group_id="O3" value="162"/>
                    <count group_id="O4" value="141"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="5.0"/>
                    <measurement group_id="O2" value="10.3" spread="6.0"/>
                    <measurement group_id="O3" value="9.6" spread="4.5"/>
                    <measurement group_id="O4" value="7.8" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Exit examination</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="325"/>
                    <count group_id="O2" value="318"/>
                    <count group_id="O3" value="166"/>
                    <count group_id="O4" value="298"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8" spread="3.8"/>
                    <measurement group_id="O2" value="7.8" spread="4.7"/>
                    <measurement group_id="O3" value="7.9" spread="4.0"/>
                    <measurement group_id="O4" value="8.1" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage Change From Baseline in BMD Measured at Lumbar Spine (Other Time Points Not Mentioned as Primary Safety Variable) and Hip/Femoral Neck</title>
        <description>Percentage change in BMD (measured by dual-energy X-ray absorptiometry (DEXA) scan) of lumbar spine (other time points not mentioned as primary safety analysis), hip, and femoral neck from baseline was analyzed using the same statistical methods as used for the primary variable.</description>
        <time_frame>Up to 2 years</time_frame>
        <population>SAF was analyzed. Percentage change from baseline in BMD of lumbar spine, hip and femoral neck was presented by time interval in below table.</population>
        <group_list>
          <group group_id="O1">
            <title>Vilaprisan 2 mg A1 (3/1 Regimen)</title>
            <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode</description>
          </group>
          <group group_id="O2">
            <title>Vilaprisan 2 mg A2 (6/2 Regimen)</title>
            <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O3">
            <title>Vilaprisan 2 mg A3 (3/2 Regimen)</title>
            <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
          </group>
          <group group_id="O4">
            <title>B (Standard of Care)</title>
            <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Change From Baseline in BMD Measured at Lumbar Spine (Other Time Points Not Mentioned as Primary Safety Variable) and Hip/Femoral Neck</title>
          <description>Percentage change in BMD (measured by dual-energy X-ray absorptiometry (DEXA) scan) of lumbar spine (other time points not mentioned as primary safety analysis), hip, and femoral neck from baseline was analyzed using the same statistical methods as used for the primary variable.</description>
          <population>SAF was analyzed. Percentage change from baseline in BMD of lumbar spine, hip and femoral neck was presented by time interval in below table.</population>
          <units>Percentage change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="349"/>
                <count group_id="O2" value="347"/>
                <count group_id="O3" value="177"/>
                <count group_id="O4" value="365"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lumbar spine - Month 6 on treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.51" spread="1.59"/>
                    <measurement group_id="O2" value="-0.49" spread="2.74"/>
                    <measurement group_id="O3" value="0.51" spread="2.52"/>
                    <measurement group_id="O4" value="-0.88" spread="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lumbar spine - End of treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="100"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="67"/>
                    <count group_id="O4" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.51" spread="2.66"/>
                    <measurement group_id="O2" value="-1.76" spread="2.64"/>
                    <measurement group_id="O3" value="-1.22" spread="2.36"/>
                    <measurement group_id="O4" value="0.12" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lumbar spine - Month 6 post treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="142"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="92"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.62" spread="3.30"/>
                    <measurement group_id="O2" value="-0.92" spread="2.72"/>
                    <measurement group_id="O3" value="-0.54" spread="2.38"/>
                    <measurement group_id="O4" value="-0.17" spread="2.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lumbar spine - Month 12 post treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="6"/>
                    <count group_id="O4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="2.81"/>
                    <measurement group_id="O2" value="-0.45" spread="3.61"/>
                    <measurement group_id="O3" value="0.86" spread="2.73"/>
                    <measurement group_id="O4" value="1.03" spread="6.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lumbar spine - End of follow up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="209"/>
                    <count group_id="O2" value="214"/>
                    <count group_id="O3" value="111"/>
                    <count group_id="O4" value="109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.53" spread="3.89"/>
                    <measurement group_id="O2" value="-0.33" spread="4.09"/>
                    <measurement group_id="O3" value="-0.53" spread="3.51"/>
                    <measurement group_id="O4" value="-0.01" spread="3.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip - Month 6 on treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.74" spread="1.83"/>
                    <measurement group_id="O2" value="-0.48" spread="2.49"/>
                    <measurement group_id="O3" value="1.61" spread="1.28"/>
                    <measurement group_id="O4" value="-0.23" spread="1.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip - Month 12 on treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="112"/>
                    <count group_id="O2" value="140"/>
                    <count group_id="O3" value="55"/>
                    <count group_id="O4" value="176"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.79" spread="2.22"/>
                    <measurement group_id="O2" value="-1.01" spread="2.22"/>
                    <measurement group_id="O3" value="-0.89" spread="2.70"/>
                    <measurement group_id="O4" value="-0.12" spread="2.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip - End of treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="100"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="65"/>
                    <count group_id="O4" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.88" spread="2.17"/>
                    <measurement group_id="O2" value="-0.94" spread="2.34"/>
                    <measurement group_id="O3" value="-0.62" spread="2.65"/>
                    <measurement group_id="O4" value="-0.15" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip - Month 6 post treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="119"/>
                    <count group_id="O2" value="135"/>
                    <count group_id="O3" value="71"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.51" spread="2.35"/>
                    <measurement group_id="O2" value="-0.60" spread="2.62"/>
                    <measurement group_id="O3" value="-0.54" spread="3.11"/>
                    <measurement group_id="O4" value="0.28" spread="2.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip - Month 12 post treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="6"/>
                    <count group_id="O4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.72" spread="1.95"/>
                    <measurement group_id="O2" value="-0.32" spread="2.00"/>
                    <measurement group_id="O3" value="1.41" spread="2.22"/>
                    <measurement group_id="O4" value="-0.45" spread="3.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hip - End of follow up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="204"/>
                    <count group_id="O2" value="201"/>
                    <count group_id="O3" value="109"/>
                    <count group_id="O4" value="106"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.75" spread="2.90"/>
                    <measurement group_id="O2" value="-0.12" spread="4.00"/>
                    <measurement group_id="O3" value="-0.21" spread="3.30"/>
                    <measurement group_id="O4" value="0.18" spread="2.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck - Month 6 on treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.04" spread="2.50"/>
                    <measurement group_id="O2" value="0.66" spread="3.27"/>
                    <measurement group_id="O3" value="1.30" spread="3.33"/>
                    <measurement group_id="O4" value="0.08" spread="3.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck - Month 12 on treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="112"/>
                    <count group_id="O2" value="140"/>
                    <count group_id="O3" value="55"/>
                    <count group_id="O4" value="176"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.78" spread="3.46"/>
                    <measurement group_id="O2" value="-0.65" spread="3.41"/>
                    <measurement group_id="O3" value="-0.57" spread="3.03"/>
                    <measurement group_id="O4" value="-0.14" spread="3.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck - End of treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="100"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="65"/>
                    <count group_id="O4" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.10" spread="3.40"/>
                    <measurement group_id="O2" value="-0.39" spread="3.43"/>
                    <measurement group_id="O3" value="-0.36" spread="3.19"/>
                    <measurement group_id="O4" value="-0.17" spread="3.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck - Month 6 post treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="119"/>
                    <count group_id="O2" value="135"/>
                    <count group_id="O3" value="71"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.97" spread="3.46"/>
                    <measurement group_id="O2" value="-0.45" spread="3.51"/>
                    <measurement group_id="O3" value="-0.33" spread="3.85"/>
                    <measurement group_id="O4" value="-0.41" spread="3.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck - Month 12 post treatment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="6"/>
                    <count group_id="O4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.82" spread="3.83"/>
                    <measurement group_id="O2" value="-1.23" spread="3.76"/>
                    <measurement group_id="O3" value="-0.65" spread="1.06"/>
                    <measurement group_id="O4" value="1.06" spread="5.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Femoral neck - End of follow up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="204"/>
                    <count group_id="O2" value="201"/>
                    <count group_id="O3" value="109"/>
                    <count group_id="O4" value="106"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.06" spread="4.34"/>
                    <measurement group_id="O2" value="-0.17" spread="5.36"/>
                    <measurement group_id="O3" value="-0.43" spread="4.40"/>
                    <measurement group_id="O4" value="-0.30" spread="3.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>For treatment emergent adverse events (TEAEs): From the first application of study medication up to 60 calendar days after end of treatment with study medication (mean duration is 321 days). For Post-treatment AEs: All AEs that started from Day 61 after the end of treatment with study medication (mean duration is 314 days).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Vilaprisan 2 mg A1 (3/1 Regimen) - Treatment Emergent AEs</title>
          <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode (3/1 regimen)</description>
        </group>
        <group group_id="E2">
          <title>Vilaprisan 2 mg A2 (6/2 Regimen) - Treatment Emergent AEs</title>
          <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
        </group>
        <group group_id="E3">
          <title>Vilaprisan 2 mg A3 (3/2 Regimen) - Treatment Emergent AEs</title>
          <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
        </group>
        <group group_id="E4">
          <title>Standard of Care B - Treatment Emergent AEs</title>
          <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
        </group>
        <group group_id="E5">
          <title>Vilaprisan 2 mg A1 (3/1 Regimen) - Post Treatment AEs</title>
          <description>4 treatment periods of 12 weeks, each separated by 1 bleeding episode (3/1 regimen)</description>
        </group>
        <group group_id="E6">
          <title>Vilaprisan 2 mg A2 (6/2 Regimen) - Post Treatment AEs</title>
          <description>2 treatment periods of 24 weeks, separated by 2 bleeding episodes</description>
        </group>
        <group group_id="E7">
          <title>Vilaprisan 2 mg A3 (3/2 Regimen) - Post Treatment AEs</title>
          <description>3 treatment periods of 12 weeks, each separated by 2 bleeding episodes</description>
        </group>
        <group group_id="E8">
          <title>Standard of Care B - Post Treatment AEs</title>
          <description>Standard of care symptomatic nonhormonal medical treatment as determined by the investigators and/or watch and wait</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (23.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="347"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="177"/>
                <counts group_id="E4" subjects_affected="17" subjects_at_risk="365"/>
                <counts group_id="E5" subjects_affected="47" subjects_at_risk="349"/>
                <counts group_id="E6" subjects_affected="31" subjects_at_risk="347"/>
                <counts group_id="E7" subjects_affected="25" subjects_at_risk="177"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Aplastic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Venous angioma of brain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Primary hyperaldosteronism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Adrenal mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Obstructive pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Gallbladder polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Endometritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Mastitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pelvic inflammatory disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Biopsy peritoneum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Norepinephrine increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acoustic neuroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="365"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="5" subjects_affected="5" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Phyllodes tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Benign mesenteric neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Uterine myoma expulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Invasive breast carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Spinal epidural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Abortion threatened</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Umbilical cord abnormality</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Substance abuse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Cervical cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pelvic adhesions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pelvic prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Vaginal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Adenomyosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Haemorrhagic ovarian cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pelvic discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Appendicectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="365"/>
                <counts group_id="E5" events="15" subjects_affected="15" subjects_at_risk="349"/>
                <counts group_id="E6" events="10" subjects_affected="10" subjects_at_risk="347"/>
                <counts group_id="E7" events="7" subjects_affected="7" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Mastectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Myomectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="365"/>
                <counts group_id="E5" events="6" subjects_affected="6" subjects_at_risk="349"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="347"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Salpingectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Hysterosalpingo-oophorectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Spinal fusion surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Endometrial ablation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Cyst removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Intestinal adhesion lysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Hysterosalpingectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Meniscus removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Uterine dilation and curettage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Therapeutic embolisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Shoulder operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma embolisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (23.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="151" subjects_at_risk="347"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="177"/>
                <counts group_id="E4" subjects_affected="90" subjects_at_risk="365"/>
                <counts group_id="E5" subjects_affected="65" subjects_at_risk="349"/>
                <counts group_id="E6" subjects_affected="58" subjects_at_risk="347"/>
                <counts group_id="E7" subjects_affected="32" subjects_at_risk="177"/>
                <counts group_id="E8" subjects_affected="13" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="349"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="347"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="177"/>
                <counts group_id="E4" events="30" subjects_affected="29" subjects_at_risk="365"/>
                <counts group_id="E5" events="10" subjects_affected="10" subjects_at_risk="349"/>
                <counts group_id="E6" events="12" subjects_affected="12" subjects_at_risk="347"/>
                <counts group_id="E7" events="7" subjects_affected="7" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="349"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="347"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="177"/>
                <counts group_id="E4" events="20" subjects_affected="18" subjects_at_risk="365"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="51" subjects_affected="37" subjects_at_risk="349"/>
                <counts group_id="E2" events="55" subjects_affected="42" subjects_at_risk="347"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="177"/>
                <counts group_id="E4" events="16" subjects_affected="12" subjects_at_risk="365"/>
                <counts group_id="E5" events="21" subjects_affected="13" subjects_at_risk="349"/>
                <counts group_id="E6" events="16" subjects_affected="12" subjects_at_risk="347"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Bone density decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="347"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="365"/>
                <counts group_id="E5" events="18" subjects_affected="18" subjects_at_risk="349"/>
                <counts group_id="E6" events="17" subjects_affected="17" subjects_at_risk="347"/>
                <counts group_id="E7" events="5" subjects_affected="5" subjects_at_risk="177"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="43" subjects_affected="30" subjects_at_risk="349"/>
                <counts group_id="E2" events="37" subjects_affected="24" subjects_at_risk="347"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="177"/>
                <counts group_id="E4" events="13" subjects_affected="7" subjects_at_risk="365"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="349"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="347"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="349"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="347"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="177"/>
                <counts group_id="E4" events="32" subjects_affected="27" subjects_at_risk="365"/>
                <counts group_id="E5" events="23" subjects_affected="16" subjects_at_risk="349"/>
                <counts group_id="E6" events="8" subjects_affected="6" subjects_at_risk="347"/>
                <counts group_id="E7" events="9" subjects_affected="8" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" events="26" subjects_affected="16" subjects_at_risk="349"/>
                <counts group_id="E2" events="45" subjects_affected="24" subjects_at_risk="347"/>
                <counts group_id="E3" events="15" subjects_affected="9" subjects_at_risk="177"/>
                <counts group_id="E4" events="8" subjects_affected="6" subjects_at_risk="365"/>
                <counts group_id="E5" events="32" subjects_affected="15" subjects_at_risk="349"/>
                <counts group_id="E6" events="15" subjects_affected="10" subjects_at_risk="347"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="365"/>
              </event>
              <event>
                <sub_title>Endometrial thickening</sub_title>
                <counts group_id="E1" events="34" subjects_affected="28" subjects_at_risk="349"/>
                <counts group_id="E2" events="44" subjects_affected="39" subjects_at_risk="347"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="177"/>
                <counts group_id="E4" events="16" subjects_affected="13" subjects_at_risk="365"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="347"/>
                <counts group_id="E7" events="6" subjects_affected="6" subjects_at_risk="177"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="53" subjects_affected="40" subjects_at_risk="349"/>
                <counts group_id="E2" events="51" subjects_affected="44" subjects_at_risk="347"/>
                <counts group_id="E3" events="24" subjects_affected="20" subjects_at_risk="177"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="365"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E6" events="5" subjects_affected="5" subjects_at_risk="347"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="365"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Therapeutic Area Head</name_or_title>
      <organization>Bayer</organization>
      <phone>(+)1-888-84 22937</phone>
      <email>clinical-trials-contact@bayer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

